{"resourceType":"ServiceRequest","id":"mii-exa-molgen-anforderung-fgfr2-fusion","meta":{"profile":["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test"]},"identifier":[{"system":"https://www.charite.de/fhir/auftragsnummern","value":"PRK4QE59A"}],"status":"active","intent":"order","category":[{"coding":[{"system":"http://snomed.info/sct","code":"108252007","display":"Laboratory procedure (procedure)"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"405825005","display":"Molecular genetic test (procedure)"}],"text":"Therapierelevante genetische Ver√§nderungen bei Intrahepatischem Gallengangskarzinom"},"subject":{"reference":"Patient/mii-exa-molgen-patient-fgfr2-fusion"},"authoredOn":"2022-11-30","requester":{"reference":"Practitioner/mii-exa-molgen-practitioner-physician"},"reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"109842005","display":"Intrahepatic bile duct carcinoma (disorder)"},{"system":"http://fhir.de/CodeSystem/bfarm/icd-10-gm","version":"2022","code":"C22.1","display":"Intrahepatisches Gallengangskarzinom"}]}]}